Newsroom Stories

Washington University has admitted 47 rising high school sophomores to its innovative College Prep Program, a multiyear initiative that prepares high-achieving students with limited financial resources for college.

Researchers at the School of Medicine and the University of Chicago have found that a single, one-hour treatment that involves breathing in laughing gas can significantly improve symptoms in people with treatment-resistant depression.

New School of Medicine research shows that international travelers often return home with new bacterial strains jostling for position within the gut microbiome. Such travel is contributing to the rapid global increase and spread of antimicrobial resistance.

At the Washington University in St. Louis Board of Trustees meeting May 7, numerous faculty members were appointed or promoted with tenure or granted tenure, with most effective July 1.

The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The study is led by scientists at the School of Medicine and other institutions.

Researchers at Washington University School of Medicine have discovered that the immune cells stationed in the protective tissue known as the meninges come primarily from the skull. The finding opens up the possibility of developing therapies to target such cells as a way to prevent or treat brain conditions.

An interdisciplinary team at Washington University finds that combining certain data after a patient’s first treatment can predict how a breast cancer tumor is responding to chemotherapy.

Researchers at Washington University School of Medicine and Cornell University have implanted insulin-secreting cells into diabetic mice to normalize their blood sugar.

Washington University investigators now have access to a new research tool that allows them to conduct clinical studies using synthetic patient data. Synthetic data produced by the new tool, called MDClone, accurately mimics real patient data without the privacy concerns.

Olin Business School’s Tony Sardella, along with Paolo De Bona, PMBA ’20, will join the Brookings Institution for a virtual public forum on June 11 to discuss their research on the shortage of critical pharmaceutical drugs in U.S.